What is Necitumumab: Uses, Dosage, Side Effects and More

Necitumumab is a targeted cancer medication that helps treat a specific type of lung cancer called squamous non-small cell lung cancer. This medicine works by blocking proteins that help cancer cells grow and spread throughout your body.

If your doctor has mentioned necitumumab as part of your treatment plan, you likely have questions about how it works and what to expect. Let's walk through everything you need to know about this medication in a way that feels manageable and clear.

What is Necitumumab?

Necitumumab is a laboratory-made antibody that targets cancer cells specifically. Think of it as a guided missile that seeks out and attaches to cancer cells while leaving most of your healthy cells alone.

This medication belongs to a class of drugs called monoclonal antibodies. These are specially designed proteins that can recognize and stick to specific targets on cancer cells. Once attached, necitumumab helps stop the cancer from growing and may help your immune system fight the disease more effectively.

You'll receive necitumumab through an IV infusion at a cancer treatment center or hospital. The medication comes as a clear liquid that gets mixed with saline solution before being given to you through a vein.

What is Necitumumab Used For?

Necitumumab is specifically approved to treat squamous non-small cell lung cancer that has spread to other parts of your body. Your doctor will only prescribe this medication if your cancer has this particular squamous cell type.

You'll typically receive necitumumab combined with chemotherapy drugs called gemcitabine and cisplatin. This combination approach often works better than chemotherapy alone because each medication attacks the cancer in different ways.

Your oncologist will confirm that necitumumab is right for your specific situation through various tests. These may include tissue samples from your cancer and scans to see how far the disease has spread.

How Does Necitumumab Work?

Necitumumab works by blocking a protein called EGFR (epidermal growth factor receptor) that sits on the surface of cancer cells. This protein normally helps cells grow and divide, but cancer cells often have too much of it.

When necitumumab attaches to EGFR, it's like putting a lock on the door that cancer cells use to receive growth signals. This helps slow down or stop the cancer from growing and spreading to new areas of your body.

This medication is considered a moderately strong cancer treatment. While it's not as intense as some chemotherapy drugs, it still requires careful monitoring and can cause meaningful side effects that your medical team will watch for closely.

How Should I Take Necitumumab?

You'll receive necitumumab through an IV infusion that takes about 60 minutes. Your healthcare team will give you this medication at a cancer treatment center where they can monitor you closely during and after the infusion.

Before each treatment, you'll likely receive medications to help prevent allergic reactions. These might include antihistamines like Benadryl or steroids to reduce the chance of infusion reactions.

You don't need to avoid food before your necitumumab treatment, but staying well-hydrated by drinking plenty of water can help your body process the medication more effectively. Your nurse will also give you IV fluids during the treatment.

The infusion schedule typically follows a pattern where you receive necitumumab on days 1 and 8 of each 21-day treatment cycle. Your doctor will adjust this timing based on how well you're responding to treatment and how you're feeling.

How Long Should I Take Necitumumab For?

The length of necitumumab treatment varies significantly from person to person. Some people receive it for several months, while others may continue for a year or longer if it's working well and side effects remain manageable.

Your oncologist will regularly check how your cancer is responding through scans and blood tests. If the cancer starts growing again or if side effects become too difficult to handle, your doctor will discuss stopping necitumumab and exploring other treatment options.

Treatment decisions depend on several factors including how you're feeling, your scan results, and your overall health. Your medical team will have honest conversations with you about continuing or changing your treatment plan as time goes on.

What Are the Side Effects of Necitumumab?

Like most cancer medications, necitumumab can cause side effects, though not everyone experiences them the same way. Understanding what might happen can help you feel more prepared and know when to contact your healthcare team.

The most common side effects you might experience include skin problems, mouth sores, and changes in your blood levels that your doctor will monitor through regular lab tests.

Common Side Effects

These side effects happen in many people taking necitumumab, but they're usually manageable with proper care and attention:

• Skin rash or acne-like bumps, especially on your face and chest
• Dry, itchy skin that may crack or peel
• Mouth sores or pain when eating
• Diarrhea or loose stools
• Fatigue or feeling more tired than usual
• Changes in your magnesium levels
• Nail problems like infection or pain around the nail beds

Your healthcare team has experience managing these side effects and can provide medications or recommendations to help you feel more comfortable. Most of these issues improve with time or when treatment ends.

Serious Side Effects

While less common, some side effects require immediate medical attention. Knowing these warning signs helps you get help quickly if needed:

• Severe skin reactions with blistering or widespread rash
• Signs of infection like fever, chills, or unusual fatigue
• Severe diarrhea that doesn't improve with medication
• Blood clots causing leg swelling, chest pain, or shortness of breath
• Heart problems including irregular heartbeat or chest pain
• Severe allergic reactions during infusion

If you experience any of these symptoms, contact your oncology team immediately or go to the emergency room. Having a plan for reaching your medical team after hours can provide peace of mind.

Rare but Important Side Effects

Some side effects occur less frequently but still deserve attention. Your medical team will monitor for these through regular check-ups and tests:

• Severe drops in blood cell counts that increase infection risk
• Kidney problems that may change how you urinate
• Lung inflammation causing persistent cough or breathing problems
• Severe electrolyte imbalances affecting heart rhythm
• Eye problems including vision changes or pain

Regular monitoring helps catch these issues early when they're easier to manage. Your healthcare team will adjust your treatment plan if any concerning changes develop.

Who Should Not Take Necitumumab?

Necitumumab isn't suitable for everyone with lung cancer. Your doctor will carefully review your medical history and current health status before recommending this medication.

People with non-squamous types of lung cancer shouldn't receive necitumumab because studies show it doesn't help and may cause more harm than benefit in these cases. Your doctor will test your cancer tissue to confirm the squamous type before starting treatment.

If you have severe heart problems, kidney disease, or certain other medical conditions, your doctor may choose different treatment options. They'll also consider any medications you're currently taking to avoid dangerous interactions.

Pregnancy and breastfeeding are important considerations. Necitumumab can harm developing babies, so you'll need to use effective birth control during treatment and for several months afterward if you could become pregnant.

Necitumumab Brand Name

Necitumumab is sold under the brand name Portrazza. You might see either name on your medical records, insurance paperwork, or medication labels.

Whether your doctor refers to it as necitumumab or Portrazza, they're talking about the same medication. Both names appear on official prescriptions and treatment plans.

Necitumumab Alternatives

If necitumumab isn't right for you or stops working effectively, several other treatment options exist for squamous non-small cell lung cancer. Your oncologist will discuss these alternatives based on your specific situation.

Other targeted therapies like pembrolizumab (Keytruda) or nivolumab (Opdivo) work differently by helping your immune system fight cancer. These immunotherapy drugs have shown promise in treating lung cancer, though they work best in different circumstances.

Traditional chemotherapy combinations remain important treatment options. Your doctor might recommend carboplatin and paclitaxel or other combinations depending on your overall health and previous treatments.

Clinical trials offer access to newer experimental treatments that might become standard therapies in the future. Your oncologist can help you explore whether any current trials might be appropriate for your situation.

Is Necitumumab Better Than Cetuximab?

Necitumumab and cetuximab are both EGFR-targeting antibodies, but they're used for different types of cancer. Cetuximab is primarily used for colorectal and head and neck cancers, while necitumumab is specifically approved for squamous lung cancer.

Direct comparisons between these medications are difficult because they treat different cancer types. Each has been studied extensively in its approved cancer types and has shown meaningful benefits when used appropriately.

Your oncologist will choose the medication that's most appropriate for your specific cancer type and situation. The decision isn't about which drug is "better" overall, but rather which one is most likely to help your particular cancer.